Acupressure tested as cough relief for lung cancer survivors
NCT ID NCT07315672
First seen Jun 24, 2026 · Last updated Aug 12, 2026 · Updated 4 times
Summary
This study tests whether acupressure can reduce coughing and related symptoms like shortness of breath and fatigue in lung cancer survivors. Eighty participants will either perform acupressure for 8 weeks or receive an educational booklet. Researchers will track changes in cough severity and quality of life over several months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- acupressure
- What this could lead to
- If it works, this could offer a simple, drug-free way to reduce cough and improve quality of life for lung cancer survivors.
- What could go wrong
- This is a small, early-stage trial with only 80 participants. The results may not apply to everyone, and acupressure may not work better than education alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUPRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Queen Mary Hospital
RECRUITINGHong Kong, 0000, Hong Kong
-
University of Hong Kong-Shenzhen Hospital
RECRUITINGShenzhen, Guangdong, 0755, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which lung biopsy method is safer and more accurate?
- Light-Based blood test may spot lung cancer early
- Could a nebulized cocktail make lung scopes less Cough-Inducing?
- A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
- A simple arm injection may quiet a mysterious chronic cough
- Common mucus-thinning drugs may improve outcomes in COPD patients with lung cancer